Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7286 p174
14 February 2004

This article
Reprint
Photocopy


News summary

Related websites
Journal of the Science of Food and Agriculture abstract (more)


Amount of active ingredient in some St John's wort products may not match claims on product's label

Some commercial products of St John's wort (Hypericum perforatum) contain much higher or much lower amounts of active ingredient than stated on the label, say researchers from Taiwan.

Professor Miao-Lin Hu and colleagues from the National Chung-Sing University examined five St John’s wort products purchased from Californian health food stores. They used liquid chromatography methods to measure the amounts of hypericin and pseudohypericin, the two active ingredients of St John’s wort, contained in each product.

Despite none of the products listing pseudohypericin as an ingredient, it was present in all of them in higher quantities than hypericin. The actual amounts of hypericin ranged from 1.7 to 38.5 per cent of the stated amount. When the total hypericin content was measured, the amounts ranged from 2.9 to 114 per cent of the stated amount.

The study is published online in the Journal of the Science of Food and Agriculture, a journal of the Society of Chemical Industry.

Commenting on the study, Jonathan Berman, of the health and safety group at the SCI, said: “Inaccurate labelling has at least one of two effects. The first is potentially to lead to an incorrect dose when the label is complied with. The second is the potential to degrade the perceived significance of the label information among other dispensing practitioners, or patients.” This perception could then carry over to other drugs, he added.

A spokesman for the Medicines and Healthcare products Regulatory Agency told The Journal that there is evidence that some unlicensed herbal medicines available in the UK are manufactured to poor quality standards. He said: “Under the current UK regulatory arrangements it is difficult for the public to identify which products are made to good standards and which are prone to the kind of problems identified in the research.”

He added that the proposed European Directive on Traditional Herbal Medicinal Products would apply to manufactured over-the-counter herbal remedies. This will set clear standards for quality, manufacturing and labelling information.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal